Alembic Reports Mixed Financial Results with Record Sales Amid Declining Profit After Tax in May 2025

Alembic, a small-cap player in the Pharmaceuticals & Drugs industry, has reported its financial results for the quarter ending March 2025. The results, declared on May 13, 2025, indicate a notable shift in the company's evaluation, with a revision in its score reflecting recent performance metrics.
The financial data reveals that Alembic achieved its highest quarterly net sales at Rs 60.27 crore, marking a year-on-year growth of 22.90%. This positive trend in sales has been consistent over the last five quarters, suggesting a robust near-term outlook. Additionally, the operating profit reached Rs 27.33 crore, also the highest in the same timeframe, indicating favorable conditions for operational efficiency.

However, not all aspects of Alembic's financials are aligned with this positive trajectory. The profit after tax (PAT) reported at Rs 68.45 crore has shown a decline of 5.1% year-on-year, indicating challenges in this area. This mixed performance has contributed to the recent adjustment in evaluation.

For more insights on Alembic's financial trends and performance, you can Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.